Actively Recruiting
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
Led by Qilu Pharmaceutical Co., Ltd. · Updated on 2026-01-12
235
Participants Needed
2
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the efficacy and safety of QL0911 in cancer treatment-induced thrombocytopenia. Thrombocytopenia is a low number of platelets in the blood. Sometimes, thrombocytopenia is a side effect of cancer treatment.
CONDITIONS
Official Title
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women, 18-75 years of age
- Cancer confirmed by histopathological or cytological examination
- Chemotherapy cycle of 21 days
- Experienced thrombocytopenia and chemotherapy delay
- ECOG performance status 0-1
- Estimated survival time of at least 12 weeks at screening
- Current chemotherapy regimen planned for at least 2 more cycles
You will not qualify if you...
- History of hematologic diseases other than chemotherapy-induced thrombocytopenia
- Serious bleeding symptoms
- Allergy to the study drug
- Positive for hepatitis C antibody with high HCV-RNA levels
- Positive for hepatitis B surface antigen with high HBV-DNA levels
- Severe cirrhosis
- Positive for HIV or syphilis antibodies
- Pregnant or lactating women
- Received any experimental therapy within 28 days before screening
- Other conditions affecting safety or trial evaluations as decided by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Harbin First Hospital
Harbin, China
Actively Recruiting
2
Nanjing Tianyinshan Hospital
Nanjing, China
Actively Recruiting
Research Team
J
Jun Ma
CONTACT
S
Shukui Qin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here